Discover our comprehensive range of HLA Antibody Detection products, designed to meet the needs of the Transplant Diagnostics segment. From Screening and Identification to Donor Specific Antibody Identification, as well as Single Antigens, MIC Antigens, C3d and Non-HLA Antibodies, we offer a complete solution utilizing Luminex® xMAP® technology through IMMUCOR, the global leader in Transplant Diagnostics.
Immerse yourself in the ease and reliability of LIFECODES HLA antibody bead-based assays with access to Luminex®200 and FLEXMAP 3D®. These user-friendly assays deliver consistent performance and reliable results. Utilizing filter trays and vacuum manifold for washing steps, minimizing hands-on time and reducing run-to-run or tech-to-tech variabilities. Multiple negative controls ensure accurate detection of true reactivity over background, while also minimizing the prozone effect. Additionally, our assays offer CREG, Epitope, and Tail Analysis tools for enhanced interpretation and better results. Best of all, our solutions of HLA Antibodies assays can be ready in less than 1 hour!
LIFECODES LifeScreen XP is designed to maximize the amount of related HLA antigens on each bead by containing seven beads for Class I and seven beads for Class II, including beads specific for the detection of HLA-DQ and HLA-DP.
LIFECODES ID and PRA panels include LIFECODES Class I ID (PRA and Detection of HLA Class I IgG Antibodies) and LIFECODES Class II ID (PRA and Detection of HLA Class II IgG Antibodies).
The enhanced LSA assay demonstrates a lower false positive rate, increasing your ability to find acceptable donors and providing new beginnings for more transplant patients. With added coverage and specificity, our single antigen solutions improve operational efficiencies and workflow.
LIFECODES Single Antigen Assay
LIFECODES LSA Family Brochure
Publications have suggested that anti-MICA antibodies may play a role in the failure of renal allografts. The extensive representation of MICA antigens provides almost 2x the coverage compared to other kits. Reduce false positive reactions with LIFECODES's proprietary manufacturing processes that reduce non-specific reactivity.
The LIFECODES C3d Detection Assay provides a measure of the binding and processing of complement to one of its end products - C3d. When combined with LIFECODES LSA™ Single Antigen Kits, the assay offers a simple method for the detection of complement binding to HLA antibodies. Assessment of C3d fixing as part of prospective HLA monitoring can potentially aid stratification of patients at the highest risk of long-term renal allograft dysfunction.
The LIFECODES DSA assay makes it possible to screen for the presence of antibodies directed against the HLA antigens of the donor. It is ideal for pre- and post-transplant testing. Detects donor-specific HLA IgG antibodies against Class I and/or Class II antigens in a single well with the ability to freeze donor lysate for future testing. LIFECODES DSA assay values mirror Flow Cross Match Channel Shifts. You can run from 1 to 91 assays at a time.
The development of post-transplantation antibodies against Non-HLA autoantigens is associated with rejection and decreased long-term graft survival. The most convincing evidence of the importance of Non-HLA comes from reports of accelerated AMR in recipients of renal transplants from HLA identical siblings.
LIFECODES Non-HLA Antibody kit detects IgG antibodies to 60 non-HLA autoantigens. The panel was selected from an exhaustive literature search and protoarray analysis.
The MATCH IT!® Antibody software suite was designed specifically as an accessory to assist in the evaluation of test results from the LIFECODES Antibody portfolio.
Salah Alden Road | Al Zahra District
Riyadh | Kingdom of Saudi Arabia
60001 Riyadh 11545
